Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Howe

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Surgery|August 11, 1992
Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markersJ R Howe, T C Lairmore, S Dou, et al.
Henry Ford Hospital Medical Journal|January 11, 1992
Isolation of YAC clones from the pericentromeric region of chromosome 10 and development of new genetic markers linked to the multiple endocrine neoplasia type 2A geneT C Lairmore, J R Howe, S Dou, et al.
Genomics|January 11, 1991
Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2AT C Lairmore, J R Howe, J A Korte, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locusT C Lairmore, S Dou, J R Howe, et al.
Nature Genetics|May 31, 2001
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposisJ R Howe, J L Bair, M G Sayed, et al.
Human Molecular Genetics|July 1, 1993
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCH Donis-Keller, S Dou, D Chi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursL Bodei, J Mueller-Brand, R P Baum, et al.
Science (New York, N.Y.)|June 6, 1998
Mutations in the SMAD4/DPC4 gene in juvenile polyposisJ R Howe, S Roth, J C Ringold, et al.
Annals of Surgical Oncology|November 6, 2002
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposisM G Sayed, A F Ahmed, J R Ringold, et al.
Journal of Medical Genetics|July 6, 2004
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutationsJ R Howe, M G Sayed, A F Ahmed, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Surgery|August 11, 1992
Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markersJ R Howe, T C Lairmore, S Dou, et al.
Henry Ford Hospital Medical Journal|January 11, 1992
Isolation of YAC clones from the pericentromeric region of chromosome 10 and development of new genetic markers linked to the multiple endocrine neoplasia type 2A geneT C Lairmore, J R Howe, S Dou, et al.
Genomics|January 11, 1991
Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2AT C Lairmore, J R Howe, J A Korte, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locusT C Lairmore, S Dou, J R Howe, et al.
Nature Genetics|May 31, 2001
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposisJ R Howe, J L Bair, M G Sayed, et al.
Human Molecular Genetics|July 1, 1993
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCH Donis-Keller, S Dou, D Chi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursL Bodei, J Mueller-Brand, R P Baum, et al.
Science (New York, N.Y.)|June 6, 1998
Mutations in the SMAD4/DPC4 gene in juvenile polyposisJ R Howe, S Roth, J C Ringold, et al.
Annals of Surgical Oncology|November 6, 2002
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposisM G Sayed, A F Ahmed, J R Ringold, et al.
Journal of Medical Genetics|July 6, 2004
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutationsJ R Howe, M G Sayed, A F Ahmed, et al.
Pageof 9